BIOMET 3i announces bone bonding implant surface

March 4, 2008
Implant surface combines the Discrete Crystalline Deposition of nanoscale calcium phosphate particles with OSSEOTITE Surface to create a more complex microtopography at the nanoscale level.

PALM BEACH GARDENS, Fla.--The BIOMET 3i line of NanoTite Implants features a bone bonding surface and includes the NanoTite PREVAIL Implant, NanoTite Tapered Implant, NanoTite Tapered PREVAIL Implant, NanoTite Certain Implant, and the NanoTite External Connection Implant.

The implant surface combines the Discrete Crystalline Deposition of nanoscale calcium phosphate particles with the OSSEOTITE Surface to create a more complex microtopography at the nanoscale level.

Evidence-based research shows the microtopography of the OSSEOTITE Implant combined with the nanometer-scale architecture of the NanoTite Implant Surface treatment renders the surface bone bonding by the interlocking of the newly formed cement line matrix of bone with the implant surface.

Preclinical studies have shown that the NanoTite Implant surface treatment significantly improves the rate and extent of Bone-To-Implant Contact, resulting in statistically enhanced integration as compared to OSSEOTITE Implants.

Potential scenarios where such an implant might be beneficial to the patient and practice include immediate loading, placement in poor quality bone, immediate placement in extraction sockets, locations requiring short or wide implants, sinus lift augmentation and aesthetic areas.

NanoTite Implants may be used for immediate function on single tooth and/or multiple tooth applications when good primary stability is achieved.

For more information, call (800) 443-8166, (561) 776-6700, or visit the company's Web site at BIOMET 3i.

To read more about the company, go to BIOMET 3i.

For more about the topic, go to laser alternative.